Hvilken er prisen på National Graphite Corp. (NGRC)

Prisen på National Graphite Corp. (NGRC) er $0.021

Hva er markedsverdien på National Graphite Corp. (NGRC)

Markedsverdien på National Graphite Corp. (NGRC) er $3.24M

National Graphite Corp. (NGRC) Driftsmargin

National Graphite Corp. (NGRC), operating through its subsidiary Biotech Development Corp., functions as a biopharmaceutical enterprise specializing in risk and cost-sharing models. The company establishes partnerships with clinical-stage firms dedicated to developing novel biological entities or innovative therapeutic platforms. These collaborations aim to address a wide spectrum of health conditions, encompassing common illnesses, rare disorders, and those with significant unmet medical requirements. Among its key pipeline developments is ELAFIN, a drug candidate identified as a human-identical protein. ELAFIN is being developed specifically for the management of postoperative inflammatory complications. The advancement of ELAFIN is further supported by a collaboration agreement with Proteo Inc. Founded in 2006, National Graphite Corp. was formerly known as Lucky Boy Silver Corporation until it officially adopted its current name in May 2012. The company maintains its operational headquarters in Duesseldorf, Germany.

År	Driftsmargin	Endre
Ikke nok data for de angitte datoene.

År

Driftsmargin

Endre

Ikke nok data for de angitte datoene.

Selskap	Driftsmargin	Forskjell i driftsmargin	Land
Clone Algo Technologies Inc. CATI.US	0.00%	-	US
Worldwide Webb Acquisition Corp. WWAC.US	0.00%	-	US
Gushen, Inc. GSHN.US	0.00%	-	CN
Apollo Strategic Growth Capital APSG.US	0.00%	-	US
Digital World Acquisition Corp. DWAC.US	0.00%	-	US

Selskap

Driftsmargin

Forskjell i driftsmargin

Land